期刊文献+

参松养心胶囊联合瑞替普酶治疗急性ST段抬高型心肌梗死的疗效观察 认领

Observation of curative effect of Shensong Yangxin capsule combined with reteplase on acute ST-segment elevation myocardial infarction
在线阅读 下载PDF
收藏 分享 导出
摘要 目的探讨参松养心胶囊联合瑞替普酶治疗急性ST段抬高型心肌梗死的临床疗效。方法选取2018年1月至2019年12月本院收治的87例急性ST段抬高型心肌梗死患者,通过单盲法分为对照组(n=43)及实验组(n=44)。所有患者均给予常规治疗手段,对照组在此基础上给予瑞替普酶治疗,实验组在对照组基础上联合参松养心胶囊治疗。比较两组临床疗效、冠状动脉再通率、不良反应发生情况。结果实验组治疗总有效率高于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较差异无统计学意义;实验组冠状动脉再通率高于对照组,差异有统计学意义(P<0.05)。结论参松养心胶囊联合瑞替普酶治疗急性ST段抬高型心肌梗死患者,可提高临床疗效及冠状动脉再通率,不良反应发生率较低,值得临床推广应用。 Objective To explore the clinical effect of Shensong Yangxin capsule combined with reteplase in the treatment of acute ST-segment elevation myocardial infarction.Methods 87 patients with acute ST-segment elevation myocardial infarction admitted in our hospital from January 2018 to December 2019 were selected and they were divided into control group(n=43)and experimental group(n=44)by single blind method.All were given conventional treatment,the control group was given reteplase treatment,and the experimental group was treated with Shensong Yangxin capsule on the basis of the control group,comparing the clinical efficacy,coronary recanalization rate,and adverse events.Results The total effective rate of treatment in the experimental group was higher than that in the control group,and the difference was statistically significant(P<0.05);there was no significant difference in the incidence of adverse reactions between the two groups;the coronary artery recanalization rate in the experimental group was higher than that in the control group,and the difference was statistically significant(P<0.05).Conclusion The treatment of Shensong Yangxin capsule combined with reteplase in patients with acute ST-segment elevation myocardial infarction can improve clinical efficacy and coronary recanalization rate,and the incidence of adverse events is low,it is worthy of clinical promotion and application.
作者 朱宏涛 ZHU Hongtao(Department of Cardiology,Xincheng Hospital,Liaoyang Central Hospital,Liaoyang,Liaoning,111000,China)
出处 《当代医学》 2021年第5期90-92,共3页 Contemporary Medicine
关键词 急性ST段抬高型 心肌梗死 瑞替普酶 参松养心胶囊 冠状动脉再通率 Acute ST-segment elevation type Myocardial infarction Reteplase Shensong Yangxin capsule Coronary artery recanalization rate
  • 相关文献

参考文献9

二级参考文献152

共引文献1583

202103读书月活动
维普数据出版直通车
今日学术
投稿分析
职称考试

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈